CASC3 Inhibitors

CASC3 inhibitors are a class of chemical compounds that specifically target the CASC3 (Cancer Susceptibility Candidate 3) protein, which plays an essential role in the exon junction complex (EJC) involved in post-transcriptional regulation of gene expression. CASC3 is a core component of the EJC, a multi-protein complex that binds to mRNA after splicing and is involved in several important processes such as mRNA surveillance, export, translation, and localization. CASC3 contributes to stabilizing the EJC on spliced mRNAs and is thought to facilitate the regulation of mRNA degradation and translation efficiency. Inhibitors of CASC3 disrupt its interaction with other components of the EJC, leading to alterations in mRNA processing and stability, which can affect the post-transcriptional regulation of gene expression.

The development of CASC3 inhibitors involves identifying small molecules that can selectively bind to key functional domains of the CASC3 protein, particularly those that are involved in its interaction with the EJC and mRNA. By preventing CASC3 from properly assembling with the exon junction complex, these inhibitors can modulate the post-splicing activities of mRNA, potentially affecting how genes are expressed at the translational level. Structural studies of CASC3 and its role within the EJC have provided insights into the regions of the protein that are critical for its function, guiding the design of inhibitors with high specificity for CASC3. Researchers use CASC3 inhibitors as tools to study the regulatory mechanisms that control mRNA fate after splicing, offering insights into the complex processes of mRNA stability, surveillance, and the broader impact of post-transcriptional regulation on gene expression. Through these inhibitors, scientists can gain a better understanding of how disruptions in CASC3 function influence cellular processes dependent on accurate and efficient mRNA processing.